Stevia extract safeguards rats from diabetic renal injury by mitigating markers of inflammation, oxidative stress, and apoptosis

Fatma M. Othman,Mamdouh R. El-Sawi,Sameh M. Shabana,Othman, Fatma M.,Shabana, Sameh M.
DOI: https://doi.org/10.1007/s13530-023-00188-3
2023-08-11
Toxicology and Environmental Health Sciences
Abstract:Objective This study will figure out if stevia extract, a herb with anti-inflammatory and antioxidant characteristics, is effective in treating diabetic nephropathy (DN) and protecting off concerns brought on by diabetic renal impairment. Methods KIM-1, NGAL, and total protein (TP) concentrations in urine are all estimated using biochemical assays in addition to serum glucose and insulin levels. Rat serum were subjected to an ELISA analysis to assess kidney function, glutathione (GSH), and malondialdehyde (MDA). Also, apoptotic mediators alongside inflammatory markers were evaluated using this technique in rat kidney tissue. By using Hematoxylin and eosin stains, under a microscope, the histological alterations in the kidneys were studied. Results Oral administration of Stevia extract (400 mg/kg) for 30 days normalized serum glucose and insulin levels in diabetic rats compared to non-diabetic rats, indicating its antidiabetic efficacy. Stevia administration improved blood creatinine, uric acid, and TP levels in diabetic rats. Stevia's capacity to maintain GSH and lower MDA in diabetic rats' serum showed its antioxidant power. Stevia additionally inhibited the renal tissues of Type 2 diabetes mellitus (T2DM) rats from expressing Bax, caspase-3, and Cyt-c and elevating proinflammatory cytokines like IL-6, IL-1β, and TNF-α. Stevia extract therapy in diabetic rats' kidneys restored anti-antiapoptotic Bcl-2 and P53. In diabetic rats, stevia reduced urine KIM-1, NGAL, and TP levels, pointing to its anti-inflammatory and antiapoptotic characteristics. Comet length showed more DNA damage in renal tissues of diabetics than controls, but stevia extract minimized it. Ultimately, histopathological changes led to confirm these results. Conclusion To sum up, the remarkable anti-inflammatory and antiapoptotic properties of stevia extract, along with its antihyperglycemic and antioxidant actions, are responsible for its protective effects on the DN during the early stage of T2DM. Stevia may therefore be an effective and helpful approach to alleviate DN and other adverse effects.
What problem does this paper attempt to address?